ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $544,572 | +22.9% | 25,200 | +10.0% | 0.00% | – |
| Q3 2022 | $443,000 | -2.6% | 22,900 | 0.0% | 0.00% | – |
| Q2 2022 | $455,000 | -33.4% | 22,900 | 0.0% | 0.00% | – |
| Q1 2022 | $683,000 | +28.6% | 22,900 | +0.4% | 0.00% | – |
| Q4 2021 | $531,000 | -25.3% | 22,800 | 0.0% | 0.00% | – |
| Q3 2021 | $711,000 | -11.3% | 22,800 | 0.0% | 0.00% | – |
| Q2 2021 | $802,000 | +9.4% | 22,800 | +9.6% | 0.00% | – |
| Q1 2021 | $733,000 | -6.0% | 20,800 | 0.0% | 0.00% | – |
| Q4 2020 | $780,000 | +3.4% | 20,800 | -8.0% | 0.00% | – |
| Q3 2020 | $754,000 | +84.8% | 22,600 | +46.8% | 0.00% | – |
| Q2 2020 | $408,000 | +120.5% | 15,400 | +36.3% | 0.00% | – |
| Q1 2020 | $185,000 | -10.2% | 11,300 | +76.6% | 0.00% | – |
| Q2 2019 | $206,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |